Category Health/Medical

Chemotherapy could Increase Disease Susceptibility in Future Generations

An illustration of a cancer cell surrounded by healthy cells.
An illustration of a cancer cell among healthy cells. Image by CIPhotos on iStock.

A common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washington State University-led research indicates. The study, published online in iScience, found that male rats who received the drug ifosfamide during adolescence had offspring and grand-offspring with increased incidence of disease. While other research has shown that cancer treatments can increase patients’ chance of developing disease later in life, this is one of the first-known studies showing that susceptibility can be passed down to a third generation of unexposed offspring.

“The findings suggest that if a patient receives chemotherapy, and then later has children, that t...

Read More

Powerful New Tool to Advance Genomics, Disease Research

Powerful new tool to advance genomics, disease research
Image: Intrinsic cleavage biases affect single-cell ATAC-seq data analysis. Visualization of intrinsic cleavage bias effect in different cell clusters derived from scATAC-seq data for different biological samples and different experimental platforms: human hematopoietic cells (a–c), mixed human cell lines (d–f), mouse primitive gut tube (g–i), and 10× Single-Cell Multiome data for mouse embryonic brain (j–l), human peripheral blood mononuclear cells (PBMC) (m–o), and human lymph node (p–r). a, d, g, j, m, p UMAP visualization where cells are colored by cell type/labels/clusters. b, e, h, k, n, q Same UMAP visualization but cells are colored by cell bias score (CBS). c, f, i, l, o, r CBS distributions of cells from different cell types/batches/clusters...
Read More

New CRISPR-based Tool Inserts Large DNA Sequences at Desired Sites in Cells

The arm of lab scientist plucks a segment of a DNA strand.
Caption:Building on the CRISPR gene-editing system, MIT researchers designed a new tool that can snip out faulty genes and replace them with new ones.
Credits:Image: MIT News, with images from iStockphoto

Building on the CRISPR gene-editing system, MIT researchers have designed a new tool that can snip out faulty genes and replace them with new ones, in a safer and more efficient way.

Using this system, the researchers showed that they could deliver genes as long as 36,000 DNA base pairs to several types of human cells, as well as to liver cells in mice. The new technique, known as PASTE, could hold promise for treating diseases that are caused by defective genes with a large number of mutations, such as cystic fibrosis.

“It’s a new genetic way of potentially targeting these reall...

Read More

Drug Triggers Immune Cells to Attack Prostate Cancer

A drug compound stimulates immune cells to attack prostate tumors, according to new research from Washington University School of Medicine in St. Louis. Shown is a human prostate cancer organoid, a small 3D structure that serves as a model of prostate tumors. When the organoid is grown with prostate cancer patients’ immune cells, which have been treated with the drug, the immune cells attack the cancer. Red shows dead cells. Blue shows DNA.

A single drug compound simultaneously attacks hard-to-treat prostate cancer on several fronts, according to a new study in mice and human cells...

Read More